| Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage IIIA non–small-cell lung cancer (NADIM phase II trial) M Provencio, R Serna-Blasco, E Nadal, A Insa, MR García-Campelo, ... Journal of Clinical Oncology 40 (25), 2924-2933, 2022 | 253 | 2022 |
| Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition A Cruz-Bermúdez, R Laza-Briviesca, RJ Vicente-Blanco, ... Free Radical Biology and Medicine 135, 167-181, 2019 | 145 | 2019 |
| Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling A Cruz-Bermúdez, R Laza-Briviesca, RJ Vicente-Blanco, ... Free Radical Biology and Medicine 130, 163-173, 2019 | 123 | 2019 |
| Neoadjuvant chemo/immunotherapy for the treatment of stages IIIA resectable non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study—NADIM study-SLCG. M Provencio-Pulla, E Nadal-Alforja, M Cobo, A Insa, M Costa Rivas, ... Journal of Clinical Oncology 36 (15_suppl), 8521-8521, 2018 | 92 | 2018 |
| Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping J Zugazagoitia, I Ramos, JM Trigo, M Palka, A Gómez-Rueda, ... Annals of Oncology 30 (2), 290-296, 2019 | 78 | 2019 |
| Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial R Laza‐Briviesca, A Cruz‐Bermúdez, E Nadal, A Insa, ... Clinical and Translational Medicine 11 (7), e491, 2021 | 49 | 2021 |
| Lung cancer patients with COVID-19 in Spain: GRAVID study M Provencio, JMM Gallego, A Calles, M Antoñanzas, C Pangua, ... Lung cancer 157, 109-115, 2021 | 40 | 2021 |
| Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients M Provencio, M Torrente, V Calvo, D Perez-Callejo, L Gutierrez, F Franco, ... Oncotarget 9 (1), 488, 2017 | 38 | 2017 |
| Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry F Franco, E Carcereny, M Guirado, AL Ortega, R López-Castro, ... PLoS One 16 (6), e0251761, 2021 | 36 | 2021 |
| Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study I Fernández-Miranda, L Pedrosa, M Llanos, FF Franco, S Gómez, ... Clinical Cancer Research 29 (1), 209-220, 2023 | 27 | 2023 |
| Mutational profile of primary breast diffuse large B-cell lymphoma F Franco, J González-Rincón, J Lavernia, JF García, P Martín, C Bellas, ... Oncotarget 8 (61), 102888, 2017 | 27 | 2017 |
| Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients M Provencio, D Pérez-Callejo, M Torrente, P Martin, V Calvo, L Gutiérrez, ... Oncotarget 8 (35), 59408, 2017 | 19 | 2017 |
| Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data V Calvo, MA Fernández, A Collazo-Lorduy, F Franco, B Núñez, ... Lung Cancer Management 10 (4), LMT51, 2021 | 12 | 2021 |
| Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data L Gutiérrez, A Royuela, E Carcereny, R López-Castro, ... BMC cancer 21 (1), 977, 2021 | 11 | 2021 |
| Nivolumab-associated digital small-vessel vasculitis in a patient with an advanced renal cell carcinoma F Franco, M Méndez, L Gutierrez, J Sanz, V Calvo, M Provencio Immunotherapy 11 (5), 379-384, 2019 | 11 | 2019 |
| Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial B Sierra-Rodero, A Cruz-Bermúdez, E Nadal, Y Garitaonaindía, A Insa, ... Journal for immunotherapy of cancer 9 (8), 2021 | 9 | 2021 |
| Long-term follow up of Hodgkin lymphoma D Perez-Callejo, L Zurutuza, A Royuela, M Torrente, B Núñez, V Calvo, ... Oncotarget 9 (14), 11638, 2018 | 9 | 2018 |
| Renoprotección en diabetes e hipertensión: Revisión bibliográfica de la conducta actual JA García, VC Gonseski, TP González, FF Franco Rev Postgr VIa Cáted Med 144, 11-5, 2005 | 9 | 2005 |
| Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer F Franco, M Provencio Journal of Thoracic Disease 11 (10), 4092, 2019 | 7 | 2019 |
| Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study M Provencio, D Rodríguez-Abreu, AL Ortega, G Serrano, C Aguado, ... Translational Lung Cancer Research 11 (1), 53, 2022 | 6 | 2022 |
